Nipro | Infraredx

Nipro Company

Network

Contact Us

Home

Coronary Artery Disease

Products

Makoto™ Imaging System NIPRO OKAY® II GM-30 Inflation Device

Clinical Evidence

PROSPECT II & PROSPECT ABSORB Study LRP Study

About Us

Events News

Education

Resources

PACMAN-AMI Clinical Trial Findings Published
The PACMAN-AMI Clinical Trial Findings were published in JAMA, April 3, 2022. Read how the addition of subcutaneous biweekly alirocumab, compared with placebo, to high-intensity statin therapy resulted in significantly greater coronary plaque regression in non–infarct-related arteries after 52 weeks.

VIEW NOW

Careers Intellectual Property Terms and Conditions Privacy Policy Copyright Site Map

Keep up with us.*

Infraredx, a Nipro Company
28 Crosby Drive, Suite 100
Bedford, MA 01730
+1.888.680.REDX (7339)

© 2020 Infraredx™, Inc. All Rights Reserved Powered by Bloom Creative